Literature DB >> 20447415

Severe acute renal failure associated with rhabdomyolysis during treatment with raltegravir. A call for caution.

Mar Masiá, Ricardo Enríquez, Ana Sirvent, Félix Gutiérrez.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20447415     DOI： 10.1016/j.jinf.2010.04.011

Source DB:  PubMed          Journal:  J Infect        ISSN： 0163-4453            Impact factor:   6.072


× No keyword cloud information.
  10 in total

Review 1.  Renal disease in HIV-infected individuals.

Authors:  John Phair; Frank Palella
Journal:  Curr Opin HIV AIDS       Date:  2011-07       Impact factor: 4.283

Review 2.  Prescribing for patients taking antiretroviral therapy.

Authors:  Yasmin Hughes; Louise Tomlins; Tim Usherwood
Journal:  Aust Prescr       Date:  2022-06-01

Review 3.  Renal effects of novel antiretroviral drugs.

Authors:  James Milburn; Rachael Jones; Jeremy B Levy
Journal:  Nephrol Dial Transplant       Date:  2017-03-01       Impact factor: 5.992

4.  Role of raltegravir in the management of HIV-1 infection.

Authors:  N Lance Okeke; Charles Hicks
Journal:  HIV AIDS (Auckl)       Date:  2011-07-15

5.  96 Week follow-up of HIV-infected patients in rescue with raltegravir plus optimized backbone regimens: a multicentre Italian experience.

Authors:  Amedeo Capetti; Simona Landonio; Paola Meraviglia; Antonio Di Biagio; Sergio Lo Caputo; Gaetana Sterrantino; Adriana Ammassari; Barbara Menzaghi; Marco Franzetti; Giuseppe Vittorio De Socio; Giovanni Pellicanò; Elena Mazzotta; Alessandro Soria; Marianna Meschiari; Michele Trezzi; Lolita Sasset; Benedetto Maurizio Celesia; Patrizia Zucchi; Sara Melzi; Elena Ricci; Giuliano Rizzardini
Journal:  PLoS One       Date:  2012-07-11       Impact factor: 3.240

Review 6.  Renal effects of non-tenofovir antiretroviral therapy in patients living with HIV.

Authors:  Milena M McLaughlin; Aimee J Guerrero; Andrew Merker
Journal:  Drugs Context       Date:  2018-03-21

7.  Risk of elevation of serum creatine kinase among HIV-positive individuals receiving dolutegravir-based combination antiretroviral therapy.

Authors:  Guan-Jhou Chen; Hsin-Yun Sun; Aristine Cheng; Yu-Chung Chuang; Yu-Shan Huang; Kuan-Yin Lin; Yi-Chia Huang; Wen-Chun Liu; Pei-Ying Wu; Chien-Ching Hung; Shan-Chwen Chang
Journal:  Medicine (Baltimore)       Date:  2019-06       Impact factor: 1.817

8.  A suspected case of hyponatraemia induced rhabdomyolysis: a case report.

Authors:  Edward Reakes; Douglas Drak; David Gracey
Journal:  BMC Nephrol       Date:  2022-05-11       Impact factor: 2.585

Review 9.  HIV-1 Integrase Inhibitors: A Comparative Review of Efficacy and Safety.

Authors:  Kimberly K Scarsi; Joshua P Havens; Anthony T Podany; Sean N Avedissian; Courtney V Fletcher
Journal:  Drugs       Date:  2020-11       Impact factor: 9.546

10.  Factors affecting glomerular filtration rate, as measured by iohexol disappearance, in men with or at risk for HIV infection.

Authors:  Joseph B Margolick; Lisa P Jacobson; George J Schwartz; Alison G Abraham; Annie T Darilay; Lawrence A Kingsley; Mallory D Witt; Frank J Palella
Journal:  PLoS One       Date:  2014-02-07       Impact factor: 3.240
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.